Crossmark

Predominance of Nootropic or Anxiolytic Effects of Selank, Semax, and Noopept Peptides Depending on the Route of Administration to BALB/c and С57BL/6 Mice

Crossref DOI link: https://doi.org/10.1134/S1819712420030113

Published Online: 2020-09-23

Published Print: 2020-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vasileva, E. V.

Kondrakhin, E. A.

Abdullina, A. A.

Salimov, R. M.

Kovalev, G. I.
License Information

Text and Data Mining valid from 2020-07-01

Version of Record valid from 2020-07-01
More Information

Article History

Received: 6 January 2020

Revised: 28 March 2020

Accepted: 9 April 2020

First Online: 23 September 2020

COMPLIANCE WITH ETHICAL STANDARDS

: <i>Conflict of interests</i>. The authors declare that they have no conflicts of interest.

: <i>Ethical statement</i>. The animals were treated in accordance with the Rules for Laboratory Practice for performing preclinical studies in the Russian Federation (GOST 351.000.3-96 and 51000.4-96), Order of the Ministry of Health and Social Development of the Russian Federation from August 23, 2010, no. 708n “On Approval of Rules for Laboratory Practice”. The experiments were approved by the Commission on Biomedical Ethics of the Zakusov Institute of Pharmacology.

Document is current

Any future updates will be listed below